Insider and congress filings
Becton, Dickinson and Company (BDX)
About Becton, Dickinson and Company
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Thomas E. Polen Jr.
- Employees
- 72,000
- Listed since
- -
- Market value
- $49.5B
- Price to earnings
- 54.2
- Earnings per share
- $3.42
- Dividend yield
- 2.21%
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q3 FY2026reported Aug 6, 2026 | $3.23 | $3.14 | $5.0B | $4.9B | EPS beatRevenue beat |
| Q2 FY2026reported May 7, 2026 | $2.90 | $2.78 | $4.7B | $4.7B | EPS beatRevenue in line |
| Q1 FY2026reported Feb 9, 2026 | $2.91 | $2.21 | $4.5B | $5.1B | EPS beatRevenue miss |
| Nov 6, 2025 | $3.96 | $3.92 | $5.9B | $5.9B | EPS in lineRevenue in line |
| Q3 FY2025reported Aug 7, 2025 | $3.68 | $3.40 | $5.5B | $5.5B | EPS beatRevenue in line |
| Q2 FY2025reported May 1, 2025 | $3.35 | $3.28 | $5.3B | $5.4B | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Dec 18, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Thomas E. PolenChairman, Chief Executive Officer and President | $1.4M | $10.0M | $5.7M | $17.1M |
| Christopher J. DelOreficeExecutive Vice President and Chief Financial Officer | $838K | $3.1M | $1.9M | $5.9M |
| Michael C. FeldExecutive Vice President, Chief Revenue Officer and Pr | $775K | $1.6M | $1.7M | $4.1M |
| Michael D. GarrisonExecutive Vice President and President, Medical Essent | $769K | $1.6M | $1.2M | $3.6M |
| Richard E. ByrdExecutive Vice President and President, Interventional | $756K | $1.4M | $1.2M | $3.4M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $3.7B | 24,592,166 | -6.0% | 8.95% |
| Vanguard Capital Management LLC | $2.7B | 17,987,834 | -2.7% | 6.55% |
| Massachusetts Financial Services Co | $2.5B | 8,650,967 | -4.9% | 3.15% |
| State Street Corp | $2.3B | 15,000,064 | +8.5% | 5.46% |
| Vanguard Portfolio Management LLC | $2.3B | 14,974,136 | -2.2% | 5.45% |
| First Eagle Investment Management, LLC | $2.1B | 13,815,335 | +15.8% | 5.03% |
| Invesco Ltd. | $1.3B | 8,898,488 | -12.5% | 3.24% |
| Geode Capital Management, LLC | $1.2B | 8,141,586 | +14.6% | 2.96% |
| Franklin Resources Inc | $1.1B | 7,011,592 | +30.7% | 2.55% |
| Wellington Management Group LLP | $962.2M | 6,357,986 | -3.9% | 2.31% |
| Greenhaven Associates Inc | $859.8M | 5,681,708 | +100.0% | 2.07% |
| Norges Bank | $631.0M | 4,169,523 | +100.0% | 1.52% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
18 filings of 370 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Michael FeldEVP, Chief Revenue Officer | Sold | 165 | $188.49 | $31K | Aug 26, 2026 | 1d |
| Thomas E. Polen Jr.Chairman, CEO and President | Sold | 4,152 | $185.00 | $768K | Aug 13, 2026 | 1d |
| Roland GoetteEVP and President, Emea | Sold | 2,438 | $180.84 | $441K | Aug 11, 2026 | 1d |
| Michael FeldEVP, Chief Revenue Officer | Sold | 75 | $157.13 | $12K | Jul 27, 2026 | 1d |
| Michael FeldEVP, Chief Revenue Officer | Sold | 75 | $152.80 | $11K | Jun 26, 2026 | 0d |
| Michael David GarrisonEVP & Pres Med.essntl&biopharm | Sold | 1,100 | $145.66 | $160K | Jun 24, 2026 | 1d |
| Michael David GarrisonEVP & Pres Med.essntl&biopharm | Sold | 1,100 | $151.48 | $167K | Jun 10, 2026 | 1d |
| Thomas E. Polen Jr.Chairman, CEO and President | Sold | 2,764 | $146.35 | $405K | Jun 1, 2026 | 2d |
| Michael FeldEVP, Chief Revenue Officer | Sold | 75 | $147.35 | $11K | May 26, 2026 | 1d |
| Michael FeldEVP, Chief Revenue Officer | Sold | 74 | $151.94 | $11K | Apr 27, 2026 | 1d |
| Michael FeldEVP, Chief Revenue Officer | Sold | 75 | $156.83 | $12K | Mar 26, 2026 | 1d |
| Michael FeldEVP, Chief Revenue Officer | Sold | 75 | $181.84 | $14K | Feb 26, 2026 | 1d |
| Bertram L. ScottDirector | Sold | 953 | $182.61 | $174K | Feb 18, 2026 | 0d |
| Michael FeldEVP, CRO & Pres. Life Sciences | Sold | 75 | $202.73 | $15K | Jan 26, 2026 | 2d |
| Michael David GarrisonEVP & Pres Med.essntl&biopharm | Sold · 2 lines | 1,610 | $207.46 | $334K | Jan 15, 2026 | 1d |
| Michael FeldEVP, CRO & Pres. Life Sciences | Sold | 74 | $196.08 | $15K | Dec 26, 2025 | 3d |
| Michael David GarrisonEVP & Pres Med.essntl&biopharm | Sold | 629 | $196.03 | $123K | Dec 17, 2025 | 0d |
| Michael FeldEVP, CRO & Pres. Life Sciences | Sold | 75 | $193.36 | $15K | Dec 1, 2025 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in BDX
20 disclosures of 133 on record · median 28d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +16.4%S&P +20.2% · vs S&P 500 -3.9% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +24.5%S&P +0.4% · vs S&P 500 +24.1% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Thomas H. Kean, Jr. | Stock | Sale | $1,001 - $15,000 | +22.9%S&P +2.6% · vs S&P 500 +20.3% | May 21, 2026 | Jun 18, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +22.1%S&P +1.6% · vs S&P 500 +20.5% | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +25.3%S&P +3.2% · vs S&P 500 +22.2% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +20.4%S&P +5.8% · vs S&P 500 +14.6% | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +18.2%S&P +6.8% · vs S&P 500 +11.4% | Apr 24, 2026 | May 11, 2026 | 17d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +15.2%S&P +11.6% · vs S&P 500 +3.6% | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +15.1%S&P +16.0% · vs S&P 500 -0.9% | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | +11.2%S&P +13.6% · vs S&P 500 -2.4% | Mar 17, 2026 | Apr 3, 2026 | 17d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | -10.6%S&P +9.8% · vs S&P 500 -20.4% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -10.9%S&P +10.6% · vs S&P 500 -21.5% | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -1.0%S&P +11.9% · vs S&P 500 -12.9% | Nov 10, 2025 | Dec 8, 2025 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +1.4%S&P +11.6% · vs S&P 500 -10.1% | Nov 3, 2025 | Dec 8, 2025 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -2.3%S&P +14.9% · vs S&P 500 -17.1% | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +0.5%S&P +20.8% · vs S&P 500 -20.3% | Aug 4, 2025 | Sep 9, 2025 | 36d |
| Lisa C. McClainSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +4.8%S&P +25.5% · vs S&P 500 -20.6% | Jun 24, 2025 | Aug 13, 2025 | 50d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +5.8%S&P +27.8% · vs S&P 500 -21.9% | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Thomas H. Kean, Jr. | Stock | Purchase | $1,001 - $15,000 | +2.6%S&P +30.1% · vs S&P 500 -27.5% | May 13, 2025 | Jun 17, 2025 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +1.6%S&P +28.2% · vs S&P 500 -26.6% | May 19, 2025 | Jun 10, 2025 | 22d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
5 members · estimate, as of Sep 10, 20265 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Tom Cole | Republican · House | $50,001 - $100,000 | 8.9% |
| Debbie Dingell | Democrat · House | $15,001 - $50,000 | 0.4% |
| Jacky Rosen | Democrat · Senate | $15,001 - $50,000 | 0.4% |
| Thomas H. Kean, Jr. | Republican · House | $15,001 - $50,000 | 0.5% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Vitor RoqueEVP & Chief Financial Officer | Tax withholding | 190 | Sep 2, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Tax withholding | 1,049 | Aug 20, 2026 |
| Thomas E. Polen Jr.Chairman, CEO and President | Option exercise | 43,278 | Aug 13, 2026 |
| Thomas E. Polen Jr.Chairman, CEO and President | Disposed to issuer | 39,126 | Aug 13, 2026 |
| Robert Luther HuffinesDirector | Stock award | 189 | Aug 6, 2026 |
| Carrie L. ByingtonDirector | Stock award | 94 | Aug 6, 2026 |
| Bilal MuhsinEVP & President Connected Care | Tax withholding | 1,935 | Jul 2, 2026 |
| Bilal MuhsinEVP & President Connected Care | Stock award | 14,342 | Jul 1, 2026 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 3,555 | Nov 26, 2022 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 4,100 | Nov 26, 2019 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 3,408 | Nov 26, 2023 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 4,174 | Nov 26, 2018 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 5,690 | Nov 26, 2021 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 3,147 | Nov 26, 2024 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 2,663 | Nov 26, 2025 |
| Manish SinhaEVP and Chief People Officer | Form 4 | 4,441 | Nov 26, 2020 |
| Thomas E. Polen Jr.Chairman, CEO and President | Option exercise | 20,209 | Jun 1, 2026 |
| Thomas E. Polen Jr.Chairman, CEO and President | Disposed to issuer | 17,445 | Jun 1, 2026 |
| Peter MenziusoEVP and President, BDI | Stock award | 14,258 | Jun 1, 2026 |
| Carrie L. ByingtonDirector | Stock award | 105 | May 8, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling BDX?
Across the 18 most recent open-market filings shown here, 0 were purchases and 18 were sales.
Which members of Congress have traded BDX?
Alan Armstrong, Ro Khanna, Thomas H. Kean, Jr., Kevin Hern, Lisa C. McClain disclosed BDX transactions in the filings shown here.
Which members of Congress hold BDX?
5 members of Congress report a position in BDX in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Tom Cole, Debbie Dingell and Jacky Rosen. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is BDX in the S&P 500 or the Nasdaq 100?
Becton, Dickinson and Company is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are BDX trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.